New hydrazine and hydrazide quinoxaline 1,4-di-N-oxide derivatives: In silico ADMET, antiplasmodial and antileishmanial activity
Keywords: لیشمانیاز; ACTs; artemisinin-based combination therapies; QdNO; quinoxaline 1,4-di-N-oxide; SAR; structure-activity relationship; VL; virtual library; SI; selectivity index; TPSA; topological polar surface area; %ABS; human intestinal absorption; Malaria; Leishmania